Obstacles cleared for Bertagnolli’s confirmation as NIH director Senate HELP Committee schedules hearing

KU Cancer Center and Health System receive $20M in new federal investments

The University of Kansas Cancer Center and the University of Kansas Health System received $20 million in new federal investments.

August 02, 2024

Vol.50 No.31

Clinical Trials & Tribulations

Better oncology drug management could lead to improved outcomes, lower costs

Cancer treatment is steadily improving. The proof can be found in the number of patients with cancer living longer than ever before. Over the next decade, the number of people who have lived five or more years after their diagnosis is projected to increase approximately 30% to 16.3 million.

July 26, 2024

Vol.50 No.30

By Matt Ingram

Clinical Roundup

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

To help accelerate research into new treatments for acute myeloid leukemia and myelodysplastic syndrome, Thermo Fisher Scientific Inc. is partnering with NCI on the myeloMATCH (Molecular Analysis for Therapy Choice) precision medicine umbrella trial.

July 26, 2024

Vol.50 No.30

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.

July 19, 2024

Vol.50 No.29

By Jacquelyn Cobb

Conversation with The Cancer Letter

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

What can NCI accomplish in data science?

July 12, 2024

Vol.50 No.28

By Paul Goldberg

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

Kate Choi grew up hearing conversations about skin cancer. Her grandparents had it, as did her cousins.

June 28, 2024

Vol.50 No.26

By McKenzie Prillaman

Obstacles cleared for Bertagnolli’s confirmation as NIH director

Senate HELP Committee schedules hearing

YOU MAY BE INTERESTED IN

KU Cancer Center and Health System receive $20M in new federal investments

Better oncology drug management could lead to improved outcomes, lower costs

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists

Renew today!

Subscriber content

Login

Obstacles cleared for Bertagnolli’s confirmation as NIH director

Senate HELP Committee schedules hearing

YOU MAY BE INTERESTED IN

KU Cancer Center and Health System receive $20M in new federal investments

Better oncology drug management could lead to improved outcomes, lower costs

Thermo Fisher, NCI collaborate to advance myeloid cancer research, treatment utilizing next-gen sequencing technology

Platinum drugs are off the shortage list, but the underlying problem is unsolvedFDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forwardNCI’s Youth Enjoy Science (YES) program also invests in student scientists

Login

Platinum drugs are off the shortage list, but the underlying problem is unsolved
FDA’s Califf: “We have a market failure due to unwillingness of health systems and cancer centers to pay a fair price.”

NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”

High school science competitions shaped the careers of Regeneron’s co-founders—now, they’re paying it forward
NCI’s Youth Enjoy Science (YES) program also invests in student scientists